vs
Side-by-side financial comparison of REED'S, INC. (REED) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
REED'S, INC. is the larger business by last-quarter revenue ($7.5M vs $5.5M, roughly 1.4× Taysha Gene Therapies, Inc.). REED'S, INC. runs the higher net margin — -50.5% vs -507.8%, a 457.2% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs -23.1%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -11.7%).
Waddell & Reed Financial, Inc. was an American asset management and financial planning company founded in 1937 in Kansas City, Missouri. It was a publicly traded company from 1998 to 2021, and briefly had its headquarters in Overland Park, Kansas, and was planning a move back to Downtown Kansas City before the company was sold. It operated asset management and distribution subsidiaries, including Ivy Investment Management Company and Waddell & Reed Investment Management Company.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
REED vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.5M | $5.5M |
| Net Profit | $-3.8M | $-27.9M |
| Gross Margin | 20.4% | — |
| Operating Margin | -46.9% | -516.0% |
| Net Margin | -50.5% | -507.8% |
| Revenue YoY | -23.1% | 171.3% |
| Net Profit YoY | 8.2% | -48.3% |
| EPS (diluted) | $-1.26 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.5M | $5.5M | ||
| Q3 25 | $7.0M | $0 | ||
| Q2 25 | $9.5M | $2.0M | ||
| Q1 25 | $10.0M | $2.3M | ||
| Q4 24 | $9.7M | $2.0M | ||
| Q3 24 | $6.8M | $1.8M | ||
| Q2 24 | $11.9M | $1.1M | ||
| Q1 24 | $9.6M | $3.4M |
| Q4 25 | $-3.8M | $-27.9M | ||
| Q3 25 | $-4.0M | $-32.7M | ||
| Q2 25 | $-6.0M | $-26.9M | ||
| Q1 25 | $-2.0M | $-21.5M | ||
| Q4 24 | $-4.1M | $-18.8M | ||
| Q3 24 | $-4.2M | $-25.5M | ||
| Q2 24 | $-3.2M | $-20.9M | ||
| Q1 24 | $-1.7M | $-24.1M |
| Q4 25 | 20.4% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 8.5% | — | ||
| Q1 25 | 33.9% | — | ||
| Q4 24 | 30.0% | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | 32.3% | — | ||
| Q1 24 | 35.6% | — |
| Q4 25 | -46.9% | -516.0% | ||
| Q3 25 | -58.3% | — | ||
| Q2 25 | -60.8% | -1347.1% | ||
| Q1 25 | -17.4% | -930.5% | ||
| Q4 24 | -37.6% | -985.8% | ||
| Q3 24 | -46.5% | -1448.4% | ||
| Q2 24 | -5.6% | -1915.4% | ||
| Q1 24 | -6.8% | -713.3% |
| Q4 25 | -50.5% | -507.8% | ||
| Q3 25 | -56.6% | — | ||
| Q2 25 | -63.5% | -1353.6% | ||
| Q1 25 | -20.3% | -935.2% | ||
| Q4 24 | -42.3% | -929.0% | ||
| Q3 24 | -61.5% | -1427.5% | ||
| Q2 24 | -27.1% | -1882.0% | ||
| Q1 24 | -17.4% | -705.4% |
| Q4 25 | $-1.26 | $-0.08 | ||
| Q3 25 | $-0.48 | $-0.09 | ||
| Q2 25 | $-0.13 | $-0.09 | ||
| Q1 25 | $-0.04 | $-0.08 | ||
| Q4 24 | $-3.73 | $-0.07 | ||
| Q3 24 | $-4.91 | $-0.10 | ||
| Q2 24 | $-0.77 | $-0.09 | ||
| Q1 24 | $-0.40 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.2M | $246.9M |
| Total Assets | $23.3M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $319.8M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $312.8M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $139.0M | ||
| Q3 24 | — | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | — | $124.0M |
| Q4 25 | $9.2M | $246.9M | ||
| Q3 25 | $2.8M | $219.0M | ||
| Q2 25 | $1.7M | $248.7M | ||
| Q1 25 | $4.7M | $55.1M | ||
| Q4 24 | $6.6M | $71.5M | ||
| Q3 24 | $-22.0M | $88.8M | ||
| Q2 24 | $-23.8M | $108.9M | ||
| Q1 24 | $-20.7M | $53.8M |
| Q4 25 | $23.3M | $343.3M | ||
| Q3 25 | $19.9M | $316.6M | ||
| Q2 25 | $23.7M | $333.3M | ||
| Q1 25 | $24.5M | $138.4M | ||
| Q4 24 | $25.1M | $160.4M | ||
| Q3 24 | $15.0M | $180.2M | ||
| Q2 24 | $18.7M | $200.4M | ||
| Q1 24 | $19.3M | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $-26.7M |
| Free Cash FlowOCF − Capex | $-3.9M | — |
| FCF MarginFCF / Revenue | -52.0% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-17.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $-26.7M | ||
| Q3 25 | $-2.8M | $-24.2M | ||
| Q2 25 | $-5.0M | $-20.2M | ||
| Q1 25 | $-5.4M | $-22.0M | ||
| Q4 24 | $-3.9M | $-18.3M | ||
| Q3 24 | $1.1M | $-21.6M | ||
| Q2 24 | $-912.0K | $-21.5M | ||
| Q1 24 | $-2.4M | $-19.8M |
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $-2.9M | $-24.3M | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $-4.0M | $-18.3M | ||
| Q3 24 | $1.0M | $-21.6M | ||
| Q2 24 | $-924.0K | $-21.7M | ||
| Q1 24 | $-2.4M | $-19.9M |
| Q4 25 | -52.0% | — | ||
| Q3 25 | -41.5% | — | ||
| Q2 25 | -53.2% | — | ||
| Q1 25 | -54.2% | — | ||
| Q4 24 | -40.8% | -905.5% | ||
| Q3 24 | 15.3% | -1210.9% | ||
| Q2 24 | -7.8% | -1951.9% | ||
| Q1 24 | -25.1% | -584.5% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 1.0% | 0.1% | ||
| Q3 24 | 0.3% | 2.0% | ||
| Q2 24 | 0.1% | 18.1% | ||
| Q1 24 | 0.2% | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
